Effect of diabetes on biodistribution, nephrotoxicity and antitumor activity of cisplatin in mice
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 229, 119-131
Abstract
No abstract availableKeywords
Funding Information
- CAPES
- CNPq
- FAPESP (2009/11938-4)
This publication has 73 references indexed in Scilit:
- Endogenous IL-10 Attenuates Cisplatin Nephrotoxicity: Role of Dendritic CellsThe Journal of Immunology, 2010
- Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosisNephrology Dialysis Transplantation, 2010
- Determination of trace elements in biological samples by inductively coupled plasma mass spectrometry with tetramethylammonium hydroxide solubilization at room temperatureAnalytica Chimica Acta, 2009
- Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of ratsChemico-Biological Interactions, 2007
- Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c miceLife Sciences, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Anticancer Drug???Induced Kidney DisordersDrug Safety, 2001
- Sample size for the estimation of polychromatic to normochromatic erythrocyte ratio in the bone marrow micronucleus testMutation Research Letters, 1995
- The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slidesMutation Research Letters, 1990
- Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and aceton on cisplatin nephrotoxicity in Fischer 344 (F344) ratsToxicology, 1990